CLX vs KURA · P/E 15, rev $7.10B vs rev $20.9M
The Clorox Company (CLX) versus Kura Oncology Inc (KURA) — a side-by-side from cached financials, not a winner call.
The Clorox Company (CLX) is a household & personal products company listed on US.
Kura Oncology Inc (KURA) is a biotechnology company listed on NASDAQ.
Latest reported CLX revenue for 2025-06-30 was $7.10B. Net income was $824.0M. CLX currently screens at market cap $10.89B and trailing P/E 14.6.
Latest reported KURA revenue for 2026-06-30 was $20.9M. Net income was -$68.3M. Revenue was up 14.3% from 2026-03-31 to 2026-06-30. KURA currently screens at market cap $861.1M.
CLX currently screens at market cap $10.89B and trailing P/E 14.6. KURA currently screens at market cap $861.1M.
Not investment advice. Open the CLX and KURA stock pages for the full models.
Not investment advice.